vimarsana.com

Latest Breaking News On - Verastem inc - Page 1 : vimarsana.com

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Verastem, Inc (VSTM)

The law firm of Kirby McInerney LLP is investigating potential claims against Verastem, Inc. . The investigation concerns whether Verastem and/or certain of its officers have violated the federal.

Thomasw elrodVerastem incKirby mcinerneyNew york basedAttorney advertising

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Verastem, Inc (VSTM)

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Verastem, Inc (VSTM)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Thomasw elrodInvestigation of shareholder claims against verastem incVerastem incKirby mcinerneyShareholder claims against verastemNew york basedAttorney advertising

Verastem (NASDAQ:VSTM) Receives Buy Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Verastem (NASDAQ:VSTM – Free Report) in a report issued on Tuesday morning, Benzinga reports. The brokerage currently has a $17.50 target price on the biopharmaceutical company’s stock. A number of other research firms also recently commented on VSTM. Royal Bank of Canada reaffirmed an outperform rating […]

United statesVerastem incRoyal bankSectoral asset management incVanguard group incCannon global investment managementVerastem company profileCitigroup incFree reportModerate buyGet free reportCapital partnersAsset managementGlobal investment managementVanguard groupVerastem daily

Royal Bank of Canada Trims Verastem (NASDAQ:VSTM) Target Price to $16 00

Verastem (NASDAQ:VSTM – Free Report) had its target price decreased by Royal Bank of Canada from $32.00 to $16.00 in a research note released on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the biopharmaceutical company’s stock. Several other brokerages also recently commented on VSTM. HC Wainwright reiterated a […]

United statesSectoral asset management incCitigroup incYork mellon corpRoyal bankInternational assets investment managementVerastem incFree reportModerate buyStock downGet free reportAsset managementCapital partnersNew york mellon corpAssets investment managementVerastem daily

Alliance Global Partners Cuts Verastem (NASDAQ:VSTM) Price Target to $20 00

Verastem (NASDAQ:VSTM – Free Report) had its target price trimmed by Alliance Global Partners from $34.00 to $20.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also issued reports on VSTM. Royal Bank of Canada […]

United statesVerastem incCitigroup incSectoral asset management incRoyal bankInternational assets investment managementYork mellon corpAlliance global partnersFree reportModerate buyGet free reportAsset managementCapital partnersNew york mellon corpAssets investment managementVerastem daily

vimarsana © 2020. All Rights Reserved.